Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,190
New position
Shares Held
88
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#457
of 626 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Wealth Management LLC holds $7,869,904 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,276 | $2,334,208 | |
| 2 | JNJ |
Johnson & Johnson
|
8,486 | $2,155,180 | |
| 3 | NVS |
Novartis AG
|
6,045 | $947,369 | |
| 4 | AMGN |
Amgen Inc
|
1,542 | $558,386 | |
| 5 | LLY |
ELI LILLY & Co
|
370 | $443,788 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,329 | $307,055 | |
| 7 | PFE |
Pfizer Inc
|
12,072 | $290,687 | |
| 8 | NVO |
Novo Nordisk A S
|
4,946 | $237,111 |
All Filings in OGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,190 | 88 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||